PRPO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.37

Margin Of Safety %

-23

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

27.89

Target Price

Analyst Recom

Performance Q

20.05

Upside

-113.2%

Beta

1.31

Ticker: PRPO

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	PRPO	25.66	N/A	N/A	0
2026-03-10	PRPO	26.9	N/A	N/A	0
2026-03-11	PRPO	27.93	N/A	N/A	0
2026-03-12	PRPO	28.77	N/A	N/A	0
2026-03-13	PRPO	28.77	N/A	N/A	0
2026-03-17	PRPO	29.35	N/A	N/A	0
2026-03-18	PRPO	28.19	N/A	N/A	0
2026-03-20	PRPO	27.16	N/A	N/A	0
2026-03-25	PRPO	27.33	N/A	N/A	0
2026-03-26	PRPO	26.5	N/A	N/A	0
2026-03-27	PRPO	25.42	N/A	N/A	0
2026-03-30	PRPO	24.25	N/A	N/A	0
2026-03-31	PRPO	25	N/A	N/A	0
2026-04-01	PRPO	25	N/A	N/A	0
2026-04-06	PRPO	26.1	N/A	N/A	0
2026-04-07	PRPO	28	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	PRPO	26.02	-	-	-
2026-03-10	PRPO	26.90	-	-	-
2026-03-11	PRPO	27.50	-	-	-
2026-03-12	PRPO	28.77	-	-	-
2026-03-13	PRPO	27.40	-	-	-
2026-03-17	PRPO	29.40	-	-	-
2026-03-18	PRPO	29.15	-	-	-
2026-03-19	PRPO	27.49	-	-	-
2026-03-20	PRPO	27.50	-	-	-
2026-03-23	PRPO	26.94	-	-	-
2026-03-24	PRPO	26.86	-	-	-
2026-03-25	PRPO	27.23	-	-	-
2026-03-26	PRPO	27.18	-	-	-
2026-03-27	PRPO	25.19	-	-	-
2026-03-30	PRPO	24.25	-	-	-
2026-03-31	PRPO	25.86	-	-	-
2026-04-01	PRPO	25.00	-	-	-
2026-04-02	PRPO	24.91	-	-	-
2026-04-06	PRPO	26.18	-	-	-
2026-04-07	PRPO	27.89	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	PRPO	-4.02	-4.87	0.24
2026-03-10	PRPO	-4.02	-4.87	0.24
2026-03-11	PRPO	0.05	-4.87	0.22
2026-03-12	PRPO	0.05	-4.87	0.22
2026-03-13	PRPO	0.05	-4.87	0.22
2026-03-18	PRPO	0.05	-4.86	0.22
2026-03-19	PRPO	0.05	-4.86	0.22
2026-03-20	PRPO	0.05	-4.86	0.22
2026-03-23	PRPO	0.05	-4.84	0.22
2026-03-24	PRPO	0.05	-4.84	0.22
2026-03-25	PRPO	0.05	-4.84	0.38
2026-03-26	PRPO	0.05	-4.84	0.38
2026-03-27	PRPO	0.05	-4.84	0.38
2026-03-30	PRPO	0.05	-4.84	0.38
2026-03-31	PRPO	0.05	-4.84	0.38
2026-04-01	PRPO	0.05	-4.84	0.38
2026-04-02	PRPO	0.05	-4.84	0.37
2026-04-06	PRPO	0.05	-4.76	0.37
2026-04-07	PRPO	0.05	-4.76	0.37
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

0.05

Institutional Transactions

-4.76

Beta

1.31

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

21.38

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

84.8

Max Drawdown 5-Year %

-95.8

Target Price

P/E

Forward P/E

PEG

P/S

2.11

P/B

3.49

P/Free Cash Flow

141.21

EPS

-0.29

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1.51

Relative Volume

1.62

Return on Equity vs Sector %

-30

Return on Equity vs Industry %

-13.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ PRPO Healthcare

$28.50

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

4/25

Volume

3/15

Valuation

4/20

TP/AR

2/10

Options

0/10

RSI

59.5

Range 1M

61.7%

Sup Dist

13.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

11/30

Estimates

2/20

Inst/Vol

7/15

Options

0/10

EPS Yr

EPS NY

52W%

91.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -28.3% upside

Quality

4/30

Valuation

4/30

Growth

5/25

Stability

4/10

LT Trend

3/5

Upside

-28.3%

Quality

MoS

-23%

Precipio, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 61

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

PRPO

Latest News

—

Caricamento notizie per PRPO…

stock quote shares PRPO – Precipio Inc Stock Price stock today

news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch PRPO – Precipio Inc yahoo finance google finance

stock history PRPO – Precipio Inc invest stock market

stock prices PRPO premarket after hours

ticker PRPO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PRPO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y